Страна: Австралия
Език: английски
Източник: Department of Health (Therapeutic Goods Administration)
letrozole, Quantity: 2.5 mg
Medis Pharma Pty Ltd
Letrozole
Tablet, film coated
Excipient Ingredients: lactose monohydrate; maize starch; sodium starch glycollate; iron oxide yellow; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400
Oral
30
(S4) Prescription Only Medicine
Treatment of postmenopausal women with hormone receptor positive breast cancer (see "Clinical Trials"). The safety and efficacy of neoadjuvant use has not been established. Letrozole is not indicated in hormone receptor negative disease.
Visual Identification: Yellow to dark yellow round, film coated, biconvex tablet engraved with ' L' on one face and plain on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2013-05-20